Date: 2013-02-04
Type of information: Collaboration agreement
Compound:
Company: Karolinska Development (Sweden) Mayo Clinic Venture (USA)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: Karolinska Development has entered into an agreement with Mayo Clinic with the aim of identifying commercialization opportunities in Mayo’s life science innovations that will improve patient care.Through this agreement, Karolinska Development will evaluate innovations from Mayo Clinic. The collaboration will increase the possibilities for life science investments in differentiated world-class scientific innovations. Investments in commercially-interesting innovations may then be made by both parties, jointly or independently. As a not-for-profit institution, revenue that Mayo receives from such investments is used to support Mayo’s education and research endeavors.
Financial terms:
Latest news:
